Literature DB >> 23971972

The majority of HIV type 1 DNA in circulating CD4+ T lymphocytes is present in non-gut-homing resting memory CD4+ T cells.

Kristin McBride1, Yin Xu, Michelle Bailey, Nabila Seddiki, Kazuo Suzuki, John M Murray, Yuan Gao, Celine Yan, David A Cooper, Anthony D Kelleher, Kersten K Koelsch, John Zaunders.   

Abstract

Memory CD4(+) T lymphocytes in peripheral blood that express integrins α4ß7 preferentially recirculate through gut-associated lymphoid tissue (GALT), a proposed site of significant HIV-1 replication. Tregs and activated CD4(+) T cells in GALT could also be particularly susceptible to infection. We therefore hypothesized that infection of these subsets of memory CD4(+) T cells may contribute disproportionately to the HIV-1 reservoir. A cross-sectional study of CD4(+) T cell subsets of memory CD45RO(+) cells in peripheral blood mononuclear cells (PBMCs) was conducted using leukapheresis from eight subjects with untreated chronic HIV-1 infection. Real-time polymerase chain reaction (PCR) was used to quantify total and integrated HIV-1 DNA levels from memory CD4(+) T cells sorted into integrin β7(+) vs. β7(-), CD25(+)CD127(low) Treg vs. CD127(high), and activated CD38(+) vs. CD38(-). More than 80% of total HIV-1 DNA was found to reside in the integrin β7-negative non-gut-homing subset of CD45RO(+) memory CD4(+) T cells. Less than 10% was found in highly purified Tregs or CD38(+) activated memory cells. Similarly, integrated HIV-1 DNA copies were found to be more abundant in resting non-gut-homing memory CD4(+) T cells (76%) than in their activated counterparts (23%). Our investigations showed that the majority of both total and integrated HIV-1 DNA was found within non-gut-homing resting CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23971972      PMCID: PMC3785810          DOI: 10.1089/AID.2012.0351

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  75 in total

1.  HIV rebounds from latently infected cells, rather than from continuing low-level replication.

Authors:  Beda Joos; Marek Fischer; Herbert Kuster; Satish K Pillai; Joseph K Wong; Jürg Böni; Bernard Hirschel; Rainer Weber; Alexandra Trkola; Huldrych F Günthard
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-20       Impact factor: 11.205

2.  HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo.

Authors:  Amie L Meditz; Michelle K Haas; Joy M Folkvord; Kelsey Melander; Russ Young; Martin McCarter; Samantha Mawhinney; Thomas B Campbell; Yolanda Lie; Eoin Coakley; David N Levy; Elizabeth Connick
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

3.  Evidence for increased T cell turnover and decreased thymic output in HIV infection.

Authors:  D C Douek; M R Betts; B J Hill; S J Little; R Lempicki; J A Metcalf; J Casazza; C Yoder; J W Adelsberger; R A Stevens; M W Baseler; P Keiser; D D Richman; R T Davey; R A Koup
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

4.  Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells.

Authors:  Jason M Brenchley; Nitin J Karandikar; Michael R Betts; David R Ambrozak; Brenna J Hill; Laura E Crotty; Joseph P Casazza; Janaki Kuruppu; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

5.  Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.

Authors:  Steven A Yukl; Sara Gianella; Elizabeth Sinclair; Lorrie Epling; Qingsheng Li; Lijie Duan; Alex L M Choi; Valerie Girling; Terence Ho; Peilin Li; Katsuya Fujimoto; Harry Lampiris; C Bradley Hare; Mark Pandori; Ashley T Haase; Huldrych F Günthard; Marek Fischer; Amandeep K Shergill; Kenneth McQuaid; Diane V Havlir; Joseph K Wong
Journal:  J Infect Dis       Date:  2010-10-12       Impact factor: 5.226

6.  Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection.

Authors:  John J Zaunders; Susanna Ip; Mee Ling Munier; Daniel E Kaufmann; Kazuo Suzuki; Choechoe Brereton; Sarah C Sasson; Nabila Seddiki; Kersten Koelsch; Alan Landay; Pat Grey; Robert Finlayson; John Kaldor; Eric S Rosenberg; Bruce D Walker; Barbara Fazekas de St Groth; David A Cooper; Anthony D Kelleher
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  Adhesion to vascular cell adhesion molecule 1 and fibronectin. Comparison of alpha 4 beta 1 (VLA-4) and alpha 4 beta 7 on the human B cell line JY.

Authors:  B M Chan; M J Elices; E Murphy; M E Hemler
Journal:  J Biol Chem       Date:  1992-04-25       Impact factor: 5.157

8.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

9.  Peyer's patch-specific lymphocyte homing receptors consist of a VLA-4-like alpha chain associated with either of two integrin beta chains, one of which is novel.

Authors:  B Holzmann; I L Weissman
Journal:  EMBO J       Date:  1989-06       Impact factor: 11.598

10.  CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.

Authors:  Audrey L Kinter; Margaret Hennessey; Alicia Bell; Sarah Kern; Yin Lin; Marybeth Daucher; Maria Planta; Mary McGlaughlin; Robert Jackson; Steven F Ziegler; Anthony S Fauci
Journal:  J Exp Med       Date:  2004-07-26       Impact factor: 14.307

View more
  10 in total

1.  HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy.

Authors:  John M Murray; John J Zaunders; Kristin L McBride; Yin Xu; Michelle Bailey; Kazuo Suzuki; David A Cooper; Sean Emery; Anthony D Kelleher; Kersten K Koelsch
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

Review 2.  HIV Persistence in Gut-Associated Lymphoid Tissues: Pharmacological Challenges and Opportunities.

Authors:  Corbin G Thompson; Cynthia L Gay; Angela D M Kashuba
Journal:  AIDS Res Hum Retroviruses       Date:  2017-05-16       Impact factor: 2.205

3.  Envelope glycoprotein binding to the integrin α4β7 is not a general property of most HIV-1 strains.

Authors:  Lautaro G Perez; Haiyan Chen; Hua-Xin Liao; David C Montefiori
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

Review 4.  Towards an HIV-1 cure: measuring the latent reservoir.

Authors:  Katherine M Bruner; Nina N Hosmane; Robert F Siliciano
Journal:  Trends Microbiol       Date:  2015-03-05       Impact factor: 17.079

Review 5.  CD4 T Cells Mediate Both Positive and Negative Regulation of the Immune Response to HIV Infection: Complex Role of T Follicular Helper Cells and Regulatory T Cells in Pathogenesis.

Authors:  Chansavath Phetsouphanh; Yin Xu; John Zaunders
Journal:  Front Immunol       Date:  2015-01-06       Impact factor: 7.561

6.  Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype.

Authors:  John Zaunders; Wayne B Dyer; Melissa Churchill; C Mee Ling Munier; Philip H Cunningham; Kazuo Suzuki; Kristin McBride; Will Hey-Nguyen; Kersten Koelsch; Bin Wang; Bonnie Hiener; Sarah Palmer; Paul R Gorry; Michelle Bailey; Yin Xu; Mark Danta; Nabila Seddiki; David A Cooper; Nitin K Saksena; John S Sullivan; Sean Riminton; Jenny Learmont; Anthony D Kelleher
Journal:  J Virus Erad       Date:  2019-04-01

7.  HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?

Authors:  Deanna A Kulpa; Nicolas Chomont
Journal:  J Virus Erad       Date:  2015-04

8.  CD4+ T Follicular Helper and IgA+ B Cell Numbers in Gut Biopsies from HIV-Infected Subjects on Antiretroviral Therapy Are Similar to HIV-Uninfected Individuals.

Authors:  John Zaunders; Mark Danta; Michelle Bailey; Gerald Mak; Katherine Marks; Nabila Seddiki; Yin Xu; David J Templeton; David A Cooper; Mark A Boyd; Anthony D Kelleher; Kersten K Koelsch
Journal:  Front Immunol       Date:  2016-10-24       Impact factor: 7.561

9.  RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency.

Authors:  Catalina Méndez; Scott Ledger; Kathy Petoumenos; Chantelle Ahlenstiel; Anthony D Kelleher
Journal:  Retrovirology       Date:  2018-10-04       Impact factor: 4.602

10.  CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control.

Authors:  Marcial García; María Angeles Navarrete-Muñoz; José M Ligos; Alfonso Cabello; Clara Restrepo; Juan Carlos López-Bernaldo; Francisco Javier de la Hera; Carlos Barros; María Montoya; Manuel Fernández-Guerrero; Vicente Estrada; Miguel Górgolas; José M Benito; Norma Rallón
Journal:  Sci Rep       Date:  2018-10-19       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.